The new CMDF Family of Funds, which also includes the Canadian Medical Discoveries Fund, is launching two new labour-sponsored venture capital funds focused on the health and biotechnology sector: the CMDF Early Stage Fund and the CMDF Venture Fund for Ontario investors.

All three funds are 100% RSP-eligible. They also qualify as a Research Oriented Investment Funds, so investors can benefit from a tax credit of up to 35%.

The same team that has guided the CMDF since its inception will lead the new funds. Dr. Calvin Stiller will serve as chairman and CEO of the new funds, and MDS Capital Corp., will provide management services.

The CMDF Early Stage Fund will emphasize investing in health science businesses in the earlier stages of development; and the CMDF Venture Fund will focus primarily on health sciences businesses in the later stages of development.

“We think everyone should have a little biotech in their portfolio, and with a family of three funds – all offering significant tax credits — there’s something for everyone,” said Stiller. “The start of a new year is a great time to think about the future, and about making an investment that can help our pocketbooks, our economy and our world.”